What is the recommended treatment for symptom management in myasthenia gravis?

Prepare for the Adult-Gerontology Acute Care Nurse Practitioner Test. Study with interactive quizzes and detailed explanations. Boost your exam readiness with our diverse question formats and in-depth content coverage.

Symptom management in myasthenia gravis centers on improving neuromuscular transmission by increasing acetylcholine availability at the neuromuscular junction. Acetylcholinesterase inhibitors accomplish this by blocking the breakdown of acetylcholine, allowing it to act longer and more effectively at the receptor sites. Pyridostigmine bromide is the preferred choice because it provides reliable, long-acting relief of weakness with an acceptable side-effect profile and is easy to administer orally for ongoing daily control.

While corticosteroids can reduce the underlying autoimmune activity, they are not primarily used for rapid symptom relief and come with broader systemic risks. Immunoglobulin therapy is useful in rapid immunomodulation for crisis or perioperative situations, not routine symptom management. Decongestants do not influence neuromuscular transmission and have no role here.

So, the best answer is an acetylcholinesterase inhibitor like pyridostigmine bromide for ongoing symptom control.